Status:

COMPLETED

The MARS® Albumin Dialysis System in Patients With Fulminant and Subfulminant Hepatic Failure

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Hepatitis

Eligibility:

All Genders

18-70 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to improve the survival rate of those patients with acute fulminant hepatitis through treatment with the MARS® extra-corporal liver-purification system by: 1. Reducing th...

Detailed Description

Patients with fulminant or subfulminant hepatitis with either an indication or a relative contraindication to a liver transplantation, are randomized to two groups: 1. A group treated with the conven...

Eligibility Criteria

Inclusion

  • Patients with severe or sub-severe hepatitis, with an indication or a contraindication to liver transplantation

Exclusion

  • Sepsis severe not controlled
  • Haemorrhage activates not controlled
  • Clinical Obviousness of disseminated intravascular coagulation
  • Severe Pathology cardiopulmonary (NYHA \> or = 2)
  • Pregnancy, breast feeding
  • Average blood Pressure \< 40 mmHg more than 10 minutes in spite of a support by the inotrope
  • Nonhepatic coma of origin
  • Cholestases extra-hepatitic
  • Antecedents of heavy surgery in the 4 previous weeks or surgical problems unsolved
  • Absolute counter-indication with hepatic transplantation (extra Neoplasia hepatic evolutionary, irreversible cerebral Attack, irreversible multi-visceral Failure, visceral tares contra-indicating the transplantation)
  • Positive serology HIV
  • Hepatic Demonstrations of the malignant hemopathies
  • Participation in another therapeutic test in the 4 previous weeks

Key Trial Info

Start Date :

August 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2009

Estimated Enrollment :

110 Patients enrolled

Trial Details

Trial ID

NCT00224705

Start Date

August 1 2004

End Date

January 1 2009

Last Update

February 17 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hôpital Paul Brousse

Villejuif, France, 94800

The MARS® Albumin Dialysis System in Patients With Fulminant and Subfulminant Hepatic Failure | DecenTrialz